The North American Menopause Society (NAMS) recently released its 2022 Guidelines for Hormone Therapy, an update to its 2017 statement that includes significant additions based on the most current scientific evidence. To provide comprehensive and verified guidelines, NAMS recruited an Advisory Panel of experts in the field to review its 2017 Position Statement, evaluate new literature, assess the evidence, and develop updated recommendations.
The 2022 Hormone Therapy Position Statement reflects the latest research findings and recommendations, further clarifies the balance of risks and benefits of hormone therapy, and provides guidance on additional aspects of health care management relevant to patients experiencing menopause symptoms.